India’s drugs and pharmaceuticals exports rose by 2.56 percent, reaching USD 2.62 billion in September 2025, up from USD 2.56 billion in the same month last year, according to the latest data from the Ministry of Commerce & Industry.

The sector remained one of the major drivers of merchandise export growth in September 2025, alongside electronic goods, petroleum products, engineering goods, rice, and marine products.

For the six-month period from April to September 2025, India’s merchandise exports stood at USD 220.12 billion, compared with USD 213.68 billion in April–September 2024, registering a growth of 3.02 percent. When combined with services, total exports reached an estimated USD 413.30 billion, up from USD 395.71 billion in the same period last year, reflecting a growth of 4.45 percent.

Drugs & Pharmaceuticals exports rose to USD 15.38 billion during April–September 2025, up from USD 14.45 billion in the same period last year, marking a growth of 6.46 percent. 

In September 2025 alone, India’s total exports (merchandise and services) are estimated at USD 67.20 billion, up 0.78 percent from September 2024.

Electronic goods exports recorded the highest growth, surging 50.54 percent to USD 3.12 billion, followed by marine products, which rose 23.44 percent.

The top export destinations showing strong value growth during April–September 2025 include USA, UAE, China, Spain and Hong Kong.

On the import side, total imports (merchandise and services) for September 2025 reached USD 83.82 billion, marking an 11.34 percent increase over September 2024, while cumulative imports for April–September 2025 stood at USD 472.79 billion, up 3.55 percent year-on-year.